When: Thursday, May 27, 2021 from 5:30 PM to 7:00 PM (PDT)
We are excited to present this year’s Healthcare Symposium on the topic of Advances in Drug Discovery towards Mental Health Care. Anxiety disorders are the most prevalent psychiatric disorders, affecting over one third of the population during their lifetime, according to epidemiological studies. This places an immense economic burden on society, with treatments summing up to $210.5 billion annually in the US alone. Since the onset of the COVID-19 pandemic the CDC has reported a 40% increase in anxiety-related conditions amongst the US population, exacerbating this already prevalent issue to unprecedented heights. During this symposium, we will bring together various stakeholders including academics, industry professionals, investors, public health educators, and policymakers to partake in this important discussion. Stay tuned for speaker announcements!